ASPP-049

N/A

Report date: 2023/03/05 19:47:13
NME

Base Information

Drug NameASPP-049
Drug Alias NameASPP-049
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatenin beta 1 inhibitorsWnt signalling pathway stimulants
TargetsCatenin beta 1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMahidol University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A